Longboard Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.256; its P/E ratio is -9.17; Longboard Pharmaceuticals is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -15.03M	$ -12.82M	$ -14.83M	$ -11.67M	$ -11.52M
EBITDA	$ -15.03M	$ -13.03M	$ -15.20M	$ -11.67M	$ -11.68M
Net Income Common Stockholders	$ -15.03M	$ -12.82M	$ -15.00M	$ -11.15M	$ -11.13M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 48.50M	$ 56.02M	$ 63.05M	$ 76.13M	$ 67.59M
Total Assets	$ 50.70M	$ 58.86M	$ 66.22M	$ 79.68M	$ 70.62M
Total Debt	$ 475.00K	$ 502.00K	$ 589.00K	$ 683.00K	$ 740.00K
Net Debt	$ -48.02M	$ -55.51M	$ -62.46M	$ -75.44M	$ -66.85M
Total Liabilities	$ 9.77M	$ 6.82M	$ 8.12M	$ 7.55M	$ 9.15M
Stockholders Equity	$ 40.92M	$ 52.04M	$ 58.11M	$ 72.13M	$ 61.47M
Cash Flow	-
Free Cash Flow	$ -11.03M	$ -13.29M	$ -13.46M	$ -13.09M	$ -9.67M
Operating Cash Flow	$ -11.03M	$ -13.29M	$ -13.46M	$ -13.09M	$ -9.67M
Investing Cash Flow	$ -1.56M	$ 11.75M	$ 7.96M	$ 6.08M	$ 2.15M
Financing Cash Flow	$ 3.01M	$ 5.95M	$ -125.00K	$ 21.36M	$ -444.00K

Currency in USD

Longboard Pharmaceuticals Earnings and Revenue History

Income Statement >

Longboard Pharmaceuticals Debt to Assets

Balance Sheet >

Longboard Pharmaceuticals Cash Flow

Cash Flow >

Longboard Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing